Index score 83.9 (#18 overall)· Fifth-generation multiport system in broad commercial launch; FDA-cleared March 2024, with cardiac indications (including mitral valve repair) added in January 2026.· Last verified 2026-09-01
The da Vinci 5 is Intuitive Surgical's fifth-generation robotic surgery system and the volume leader's current flagship, FDA-cleared in March 2024 and now in broad commercial launch. It adds Force Feedback instruments, vastly more computing power and refreshed ergonomics to the dominant da Vinci platform, whose total installed base passed 11,700 systems in mid-2026. Cardiac indications were added in January 2026.
Installed base of 11,710 da Vinci systems worldwide as of June 30, 2026, up 12% year over year [source]
246 da Vinci 5 systems placed in Q2 2026 alone; more than 15,000 surgeons have used da Vinci 5 since launch [source]
January 2026 FDA clearances opened cardiac procedures including mitral valve repair and IMA mobilization [source]
Every spec is cited to its source with a retrieval date. verified = manufacturer-published · reported = reputable press/analyst. Verify with the manufacturer before purchase decisions.
Change timeline
milestone
Q2 2026: installed base reaches 11,710 systems; 246 da Vinci 5 placed in the quarter [source]
milestone
FDA clears da Vinci 5 for cardiac procedures including mitral valve repair [source]
launch
FDA grants 510(k) clearance for da Vinci 5 [source]
Our take
Da Vinci remains the default choice for soft-tissue robotic surgery largely because of its ecosystem: the biggest trained-surgeon pool, instrument portfolio and service network. Da Vinci 5's force feedback and data platform are real differentiators, but the system is premium-priced and locks hospitals into Intuitive's per-procedure instrument economics. New rivals (Hugo, Ottava, Versius Plus) now give buyers negotiating leverage for the first time in two decades.
Best suited for
Radical prostatectomy and other urologic procedures
Hysterectomy and benign gynecology
General surgery including hernia and colorectal
Selected cardiac procedures such as mitral valve repair (since 2026)
Intuitive does not publish prices. Press reports put da Vinci 5 about 30% above the Xi's ~$1.42M average selling price, so roughly $1.8-2M before instruments and service, which add substantial recurring cost.
How many da Vinci systems are installed worldwide?
Intuitive reported an installed base of 11,710 da Vinci systems as of June 30, 2026, of which more than 1,700 are da Vinci 5 units.
What is new in da Vinci 5 versus the Xi?
Over 150 design changes, headlined by Force Feedback instruments that let surgeons feel forces on tissue, 10,000x the computing power, improved 3D imaging and better console ergonomics.
Is the da Vinci 5 approved for heart surgery?
Yes, partially. In January 2026 the FDA cleared da Vinci 5 for certain cardiac procedures, including mitral valve repair and internal mammary artery mobilization. Intuitive is rolling these out gradually with surgeon training.
Da Vinci 5 vs Medtronic Hugo: what's the difference?
Da Vinci 5 is a single-boom multiport system with force feedback and the largest install base; Hugo uses separate modular arm carts and an open console. Hugo entered the US market in late 2025 for urology, while da Vinci is cleared across many more specialties.
Robotic-assisted minimally invasive soft-tissue surgery; US indication currently covers urologic procedures such as prostatectomy, nephrectomy and cystectomy